Helaina

Series-B
myhelaina.com Biotech & Healthcare
Total Funding $45M
Latest Round Undisclosed Series-B
Last Announced Mar 10, 2026
Investors Undisclosed
Decision Makers Profile Active

About Helaina

Helaina makes effera™, the first bio-identical human lactoferrin — a better-absorbed protein supporting gut, immune, and women's health.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters Undisclosed
Tracked Since Nov 6, 2026

Web & Domain Identity

Official Website myhelaina.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised undisclosed · Series-B

    fundraisingfox.com

  2. Capital Raise

    Raised $45,000,000 · Series-B

    news.google.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Helaina.

Funding History

2 Rounds
Series-B equity · Mar 10, 2026
Series-B equity · Sep 27, 2024
$45,000,000 news.google.com

Founders & Leadership

1

Laura Katz

Founder of Helaina

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts